Author Paul, Friedemann
-
2022 | Journal Article
Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry
Frahm, N.; Fneish, F.; Ellenberger, D.; Flachenecker, P.; Paul, F.; Warnke, C. & Kleinschnitz, C. et al. (2022)
Neurology and Therapy,. DOI: https://doi.org/10.1007/s40120-021-00320-w
Details DOI
-
2022 | Journal Article
Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Disease
Hümmert, M. W.; Schöppe, L. M.; Bellmann-Strobl, J.; Siebert, N.; Paul, F.; Duchow, A. & Pellkofer, H. et al. (2022)
Neurology, 98(11) pp. e1184-e1196. DOI: https://doi.org/10.1212/WNL.0000000000200052
Details DOI
-
2021 | Journal Article
Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder
Ayzenberg, I.; Richter, D.; Henke, E.; Asseyer, S.; Paul, F.; Trebst, C. & Hümmert, M. W. et al. (2021)
Neurology: Neuroimmunology & Neuroinflammation, 8(3) pp. e985. DOI: https://doi.org/10.1212/NXI.0000000000000985
Details DOI
-
2021 | Journal Article |
Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry
Ohle, L.-M.; Ellenberger, D. ; Flachenecker, P.; Friede, T. ; Haas, J.; Hellwig, K. & Parciak, T. et al. (2021)
Scientific Reports, 11(1) art. 13340. DOI: https://doi.org/10.1038/s41598-021-92722-x
Details DOI
-
2020 | Journal Article |
Antibody signatures in patients with histopathologically defined multiple sclerosis patterns
Stork, L.; Ellenberger, D.; Ruprecht, K.; Reindl, M.; Beißbarth, T. ; Friede, T. & Kümpfel, T. et al. (2020)
Acta Neuropathologica, 139(3) pp. 547-564. DOI: https://doi.org/10.1007/s00401-019-02120-x
Details DOI PMID PMC
-
2020 | Journal Article
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders
Ringelstein, M.; Harmel, J.; Zimmermann, H.; Brandt, A. U.; Paul, F.; Haarmann, A. & Buttmann, M. et al. (2020)
Neurology, 94(4) pp. e407-e418. DOI: https://doi.org/10.1212/WNL.0000000000008684
Details DOI
-
2020 | Journal Article |
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
Jarius, S.; Pellkofer, H. ; Siebert, N.; Korporal-Kuhnke, M.; Hümmert, M. W.; Ringelstein, M. & Rommer, P. S. et al. (2020)
Journal of Neuroinflammation, 17(1). DOI: https://doi.org/10.1186/s12974-020-01824-2
Details DOI
-
2019 | Journal Article |
Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany
Bittner, S.; Engel, S.; Lange, C.; Weber, M. S. ; Haghikia, A.; Luessi, F. & Korn, T. et al. (2019)
Der Nervenarzt, 90(12) pp. 1245-1253-1253. DOI: https://doi.org/10.1007/s00115-019-0760-0
Details DOI PMID PMC
-
2019 | Journal Article
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
Levin, J.; Maaß, S.; Schuberth, M.; Giese, A.; Oertel, W. H; Poewe, W. & Trenkwalder, C. et al. (2019)
The Lancet Neurology, 18(8) pp. 724-735. DOI: https://doi.org/10.1016/S1474-4422(19)30141-3
Details DOI
-
2018 | Journal Article
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)
Stürner, K. H.; Stellmann, J.-P.; Dörr, J.; Paul, F.; Friede, T. ; Schammler, S. & Reinhardt, S. et al. (2018)
Journal of Neurology, Neurosurgery & Psychiatry, 89(4) pp. 330-338. DOI: https://doi.org/10.1136/jnnp-2017-317101
Details DOI
-
2017 | Journal Article
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
Stellmann, J.-P.; Krumbholz, M.; Friede, T. ; Gahlen, A.; Borisow, N.; Fischer, K. & Hellwig, K. et al. (2017)
Journal of Neurology, Neurosurgery & Psychiatry, 88(8) pp. 639-647. DOI: https://doi.org/10.1136/jnnp-2017-315603
Details DOI
-
2016 | Journal Article
MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T
Sinnecker, T.; Schumacher, S.; Mueller, K.; Pache, F.; Dusek, P. ; Harms, L. & Ruprecht, K. et al. (2016)
Neurology - Neuroimmunology Neuroinflammation, 3(4) pp. e259. DOI: https://doi.org/10.1212/NXI.0000000000000259
Details DOI
-
2016 | Journal Article
Structural Hippocampal Damage Following Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Finke, C.; Kopp, U. A.; Pajkert, A.; Behrens, J. R.; Leypoldt, F.; Wuerfel, J. T. & Ploner, C. J. et al. (2016)
Biological Psychiatry, 79(9) pp. 727-734. DOI: https://doi.org/10.1016/j.biopsych.2015.02.024
Details DOI
-
2016 | Journal Article |
Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod
Sinnecker, T.; Othman, J.; Kühl, M.; Metz, I. ; Niendorf, T.; Kunkel, A. & Paul, F. et al. (2016)
Case Reports in Neurological Medicine, 2016 pp. 1-8. DOI: https://doi.org/10.1155/2016/5876798
Details DOI
-
2016 | Journal Article |
The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach (vol 123, pg 439, 2016)
Levin, J.; Maass, S.; Schuberth, M.; Respondek, G.; Paul, F.; Mansmann, U. & Oertel, W. H. et al. (2016)
Journal of Neural Transmission, 123(11) pp. 1357-1358. DOI: https://doi.org/10.1007/s00702-016-1602-x
Details DOI PMID PMC WoS
-
2016 | Journal Article
Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study
Schumacher, S.; Pache, F.; Bellmann-Strobl, J.; Behrens, J.; Dusek, P.; Harms, L. & Ruprecht, K. et al. (2016)
Magnetic Resonance Materials in Physics Biology and Medicine, 29(3) pp. 535-541. DOI: https://doi.org/10.1007/s10334-016-0554-3
Details DOI PMID PMC WoS
-
2016 | Journal Article
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case
Jarius, S.; Metz, I.; Koenig, F. B.; Ruprecht, K.; Reindl, M.; Paul, F. & Brueck, W. et al. (2016)
Multiple Sclerosis Journal, 22(12) pp. 1541-1549. DOI: https://doi.org/10.1177/1352458515622986
Details DOI PMID PMC WoS
-
2016 | Journal Article
Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI
Wuerfel, J.; Brisset, J. Brisset, J.- C.; Liu, S.; Haacke, E. M.; Ge, Y. ; Chawla, S. & Kister, I. et al. (2016)
American Journal of Neuroradiology, 37(7) pp. 1223-1230. DOI: https://doi.org/10.3174/ajnr.A4729
Details DOI PMID PMC WoS
-
2016 | Journal Article
Monitoring of blood parameters under course-modified MS therapy. Substance-specific relevance and current recommendations for action
Klotz, L.; Berthele, A.; Brück, W. ; Chan, A.; Flachenecker, P.; Gold, R. & Haghikia, A. et al. (2016)
Der Nervenarzt, 87(6) pp. 645-659. DOI: https://doi.org/10.1007/s00115-016-0077-1
Details DOI PMID PMC WoS
-
2016 | Journal Article |
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis
Metz, I. ; Beißbarth, T. ; Ellenberger, D. ; Pache, F.; Stork, L.; Ringelstein, M. & Aktas, O. et al. (2016)
Neurology: Neuroimmunology & Neuroinflammation, 3(2) art. e204. DOI: https://doi.org/10.1212/NXI.0000000000000204
Details DOI PMID PMC